Insiders PTC Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
32.25 ^USD	+3.86%		-2.30%	+17.02%

Apr. 30	North American Morning Briefing : More Earnings -2-	DJ
Apr. 29	Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28	MT

Ptc Therapeutics Insider Sold Shares Worth $273,804, According to a Recent SEC Filing	Jan. 24	MT
Replimune Group Appoints Emily Hill as CFO	23-09-19	MT
Insider Sell: Ptc Therapeutics	23-09-08	MT
Fennec Pharmaceuticals Reports Q2 2023 Net Loss of US$5.4 Million; Appoints Adrian Haigh as Chief Operating Officer	23-08-03	MT
PTC Therapeutics Names New CFO	23-07-17	MT
PTC Therapeutics, Inc. Appoints Pierre Gravier as Chief Financial Officer	23-07-17	CI
Insider Sell: Ptc Therapeutics	23-05-23	MT
Insider Sell: Ptc Therapeutics	23-05-12	MT
Insider Sell: Ptc Therapeutics	23-04-25	MT
Insider Sell: Ptc Therapeutics	23-04-19	MT
Insider Sell: Ptc Therapeutics	23-04-19	MT
Insider Sell: Ptc Therapeutics	23-03-29	MT
Insider Sell: Ptc Therapeutics	23-03-29	MT
Insider Sell: Ptc Therapeutics	23-03-29	MT
PTC Therapeutics Shares Fall After Chief Executive Officer Exit Announcement	23-03-24	MT
PTC Therapeutics Chief Executive Stuart Peltz Retiring, Chief Operating Officer Matthew Klein Named Successor	23-03-24	MT
PTC Therapeutics, Inc. Announces CEO Changes	23-03-24	CI
PTC Therapeutics, Inc. Appoints Matthew Klein to Board of Directors	23-03-24	CI
Insider Sell: Ptc Therapeutics	23-02-02	MT
Insider Sell: Ptc Therapeutics	23-01-12	MT

No results for this search